Collaboration to improve care for children with congenital heart disease
Pediatric Heart Network - GATHER - between Washington University in St Louis and Children's Hospital Colorado
This study is working to improve care for kids with congenital heart disease by using advanced technology to understand their condition better, so they can receive better treatments and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11005032 on NIH RePORTER |
What this research studies
This research focuses on enhancing the care and outcomes for children with congenital heart disease (CHD) through a collaboration between Washington University in St. Louis and Children's Hospital Colorado. The GATHER consortium utilizes advanced research tools, including big data analytics and machine learning, to investigate various aspects of CHD, including its causes and treatment outcomes. By engaging diverse populations and training new researchers, the project aims to develop innovative solutions and improve healthcare delivery for affected children. Patients may benefit from improved treatment protocols and better understanding of their conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation are children aged 0-21 with congenital heart disease, particularly those with conditions like the absence of interventricular septum.
Not a fit: Patients with congenital heart disease who are outside the age range of 0-21 or those with unrelated cardiac conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant improvements in the treatment and management of congenital heart disease in children.
How similar studies have performed: Previous research in congenital heart disease has shown success in improving patient outcomes through collaborative and innovative approaches, indicating that this project builds on established methods.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Glatz, Andrew Charles — Washington University
- Study coordinator: Glatz, Andrew Charles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.